Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Impact of targeted tuberculosis vaccination among a mining population in South Africa: A model based studyFriday, August 9, 2024Availability, Epidemiological impactRead More
Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsideredFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
BCG and new preventive tuberculosis vaccines: Implications for healthcare workers.Friday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and IndiaFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
Estimating the potential public health value of BCG revaccinationFriday, August 9, 2024Availability, Epidemiological impactRead More
Meeting the 2030 End TB goals in the wake of COVID-19: a modelling study of countries in the USAID TB portfolio.Friday, August 9, 2024Availability, Epidemiological impactRead More
Modelling the global burden of drug-resistant tuberculosis avertable by a post-exposure vaccineFriday, August 9, 2024Availability, Epidemiological impactRead More